Mofebutazone sodium | BRN-0213056 | CAS#41468-34-2 | CAS#2210-63-1 |

MedKoo Cat#: 328606 | Name: Mofebutazone sodium

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Mofebutazone sodium, also known as BRN-0213056, is A nonsteroidal antiinflammatory drug (NSAID) used to treat joint and muscular pain.

Chemical Structure

Mofebutazone sodium

CAS#41468-34-2 (sodium); 2210-63-1 (free base)

Theoretical Analysis

MedKoo Cat#: 328606

Name: Mofebutazone sodium

CAS#: 41468-34-2 (sodium); 2210-63-1 (free base)

Chemical Formula: C13H15N2NaO2

Exact Mass:

Molecular Weight: 254.26

Elemental Analysis: C, 61.41; H, 5.95; N, 11.02; Na, 9.04; O, 12.58

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Mofebutazone sodium; BRN 0213056; BRN-0213056; BRN0213056;

IUPAC/Chemical Name

sodium 4-butyl-3,5-dioxo-2-phenylpyrazolidin-1-ide

InChi Key

FIIOKODLPLWGDK-UHFFFAOYSA-M

InChi Code

InChI=1S/C13H16N2O2.Na/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10;/h4-8,11H,2-3,9H2,1H3,(H,14,16);/q;+1/p-1

SMILES Code

O=C(C1CCCC)[N-]N(C2=CC=CC=C2)C1=O.[Na+]

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Related CAS# 2210-63-1 (Mofebutazone) 41468-34-2 (Mofebutazone sodium)

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 254.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Paradies HH. Structure of phenylbutazone and mofebutazone in the crystalline state and in solution. J Pharm Sci. 1987 Dec;76(12):920-9. PubMed PMID: 3440938. 2: Matthei U, Grabensee B, Loew D. The interaction of mofebutazone with furosemide. Curr Med Res Opin. 1987;10(9):638-44. PubMed PMID: 3481307. 3: Kamp J, Loew D, Barkow D, Deister J, Schuster O, Knoell HE. [Kinetics of mofebutazone in plasma and synovial fluid]. Z Rheumatol. 1984 Jul-Aug;43(4):179-81. German. PubMed PMID: 6495891. 4: Nielsen-Kudsk F. HPLC-determination of some antiinflammatory, weak analgesic and uricosuric drugs in human blood plasma and its application to pharmacokinetics. Acta Pharmacol Toxicol (Copenh). 1980 Oct;47(4):267-73. PubMed PMID: 6970498.